Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bob Djavan

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
European Urology|December 17, 2010
Screening for prostate cancer: practical analysis of the ERSPC [corrected] and PLCO trialsBob Djavan
BJU International|October 15, 2013
Virtual prostate biopsy and biopsy simulation: lessons to be learnedBob Djavan
European Urology|March 23, 2010
Validity and legacy of prostate-specific antigen (PSA) and PSA-based parameters and isoforms in the new millenniumBob Djavan
Current Urology Reports|June 27, 2002
Guidelines on benign prostatic hyperplasia: where do we stand in the new millennium?Bob Djavan
Urology|September 6, 2003
Lower urinary tract symptoms/benign prostatic hyperplasia: fast control of the patient's quality of lifeBob Djavan
BJU International|June 28, 2007
Editorial. Prostate cancer updateBob Djavan
The Canadian Journal of Urology|February 22, 2011
EDITORIAL COMMENT Re: Can we identify those patients who will benefit from prostate-sparing surgery? Predictive factors for invasive prostatic involvement by transitional cell carcinomaBob Djavan
Urology|April 12, 2011
Editorial commentBob Djavan
The Canadian Journal of Urology|August 23, 2011
Editorial - immunotherapy for prostate cancerBob Djavan
European Urology|December 21, 2016
Corrigendum to "Screening for Prostate Cancer: Practical Analysis of the ERSPC and PLCO Trials" [Eur Urol 2011;59:365-9]Bob Djavan
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
European Urology|December 17, 2010
Screening for prostate cancer: practical analysis of the ERSPC [corrected] and PLCO trialsBob Djavan
BJU International|October 15, 2013
Virtual prostate biopsy and biopsy simulation: lessons to be learnedBob Djavan
European Urology|March 23, 2010
Validity and legacy of prostate-specific antigen (PSA) and PSA-based parameters and isoforms in the new millenniumBob Djavan
Current Urology Reports|June 27, 2002
Guidelines on benign prostatic hyperplasia: where do we stand in the new millennium?Bob Djavan
Urology|September 6, 2003
Lower urinary tract symptoms/benign prostatic hyperplasia: fast control of the patient's quality of lifeBob Djavan
BJU International|June 28, 2007
Editorial. Prostate cancer updateBob Djavan
The Canadian Journal of Urology|February 22, 2011
EDITORIAL COMMENT Re: Can we identify those patients who will benefit from prostate-sparing surgery? Predictive factors for invasive prostatic involvement by transitional cell carcinomaBob Djavan
Urology|April 12, 2011
Editorial commentBob Djavan
The Canadian Journal of Urology|August 23, 2011
Editorial - immunotherapy for prostate cancerBob Djavan
European Urology|December 21, 2016
Corrigendum to "Screening for Prostate Cancer: Practical Analysis of the ERSPC and PLCO Trials" [Eur Urol 2011;59:365-9]Bob Djavan
Pageof 12